Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Integrin antagonists discovered as part of Lilly/Cor Therapeutics collaboration

Sep. 16, 1998

Orally active anticoagulants in early development at Gedeon Richter

Sep. 14, 1998

Antiplatelet compounds developed by Merck & Co.

Sep. 14, 1998

Antithrombotic and antiplatelet actions of combination ticlopidine/EGb-761 therapy

Sep. 9, 1998

Lepirudin more effective than heparin in preventing cardiac events in unstable angina

Sep. 9, 1998

Potent factor Xa inhibitors from RPR for thromboembolic disorders

Sep. 8, 1998

Candidate oral fibrinogen receptor antagonist presented by Uriach at ACS meeting

Sep. 7, 1998

Isoxazoline- and isoxazole-containing factor Xa inhibitors prepared by DuPont

Sep. 7, 1998

L-375052, a potent thrombin inhibitor with improved pharmacokinetics

Sep. 7, 1998

PJ-1, an antiplatelet compound with a dual mechanism of action

Sep. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...